A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the use of the study drug known as dulaglutide
in participants with type II diabetes who are taking once-daily insulin glargine. The study
will last about 31 weeks for each participant.